Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.
Hosted on MSN
Wegovy maker Novo Nordisk strikes deal with OpenAI to speed up drug discovery
Novo Nordisk said it would work with ChatGPT maker OpenAI on how to leverage artificial intelligence to discover new drugs, the latest AI partnership in the medical field as healthcare companies seek ...
Tech Times
GPT-Rosalind Drug Discovery Update: OpenAI Cuts Genomics Compute, Expands Global Access
GPT-Rosalind drug discovery capabilities updated June 3 with three new benchmarks showing the domain-specialized model cuts ...
The Motley Fool
Is This Deal a Game Changer for Novo Nordisk?
On April 14, Novo Nordisk announced that it had entered into a partnership with OpenAI. The two companies will collaborate to bring cutting-edge artificial intelligence (AI) capabilities to the drug ...